SCHEMBL31165558

SCHEMBL31165558

CN1CCC(C(=O)c2cc(Cl)nc(Cl)c2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 1/20 0.49
▸ HRH3 Q9Y5N1 1/20 0.49
▸ HTR1F P30939 8/20 0.46
▸ MGLL Q99685 2/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ KDM4A O75164 1/20 0.40
▸ CHRM5 P08912 1/20 0.40
▸ DRD5 P21918 1/20 0.40
▸ HTR1D P28221 1/20 0.40
▸ HTR1E P28566 1/20 0.40
▸ HTR7 P34969 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ TMEM97 Q5BJF2 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31047273 0.84 CNR1 (0.44) HRH3MGLLNPSR1MEN1KMT2A
SCHEMBL13391008 0.83 HRH4 (0.51) HRH4HRH3HTR1FMGLLNPSR1
SCHEMBL9220605 0.77 CHRNB2 (0.49) HTR1FMGLLLMNATP53MAPT
SCHEMBL26104132 0.77 PIK3CA (0.44) MGLL
SCHEMBL3391998 0.77 MGLL (0.69) MGLLLMNATP53MAPTL3MBTL1
SCHEMBL25153864 0.76 LMNA (0.51) LMNAL3MBTL1MEN1KMT2A
SCHEMBL29248610 0.76 LMNA (0.51) LMNAL3MBTL1MEN1KMT2A
SCHEMBL2536407 0.74 HTR1F (0.56) HRH4HRH3HTR1FMGLLNPSR1
SCHEMBL20206416 0.73 POLB (0.60) HTR1FMGLLMEN1KMT2A
SCHEMBL6578719 0.73 POLB (0.60) HRH4HRH3LMNATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695259-A1 TRICYCLIC COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS F. Hoffmann-La Roche AG (CH) 2026-02-18 — — EP disclosed
WO-2024213610-A1 TRICYCLIC COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS F. HOFFMANN-LA ROCHE AG (CH) 2024-10-17 — — WO disclosed
Send feedback